Benjamin McGraw III, Pharm.D. Venture Partner
Benjamin F. McGraw, III, is the Executive Chairman and CEO of TheraVida, Inc., a private biotechnology company, Managing Member of Long Shadows Asset Management, LLC and CEO of Auration Biotech, Inc., a private biotechnology company. He was previously Chairman and CEO of Valentis, Inc., a public biotechnology company. Prior to this, Doctor McGraw was Corporate Vice President for Corporate Development for Allergan, a public pharmaceutical company. Before that, he was a financial analyst and a fund manager at Carerra Capital Management. He began his career in pharmaceutical R&D, holding various positions including Vice-President, Development for Marion Laboratories and Marion, Merrell Dow (now Sanofi, US), both public pharmaceutical companies. Doctor McGraw earned his Bachelor of Science and Doctor of Pharmacy degrees from the University of Tennessee Center for the Health Sciences where he also completed a clinical practice residency. He’s been a member of the boards of numerous public and private biotechnology companies.